ECBK vs JAZZ · P/E 28, rev $598.0K vs P/E 1988, rev $2.28B
ECB Bancorp Inc. (ECBK) versus Jazz Pharmaceuticals PLC (JAZZ) — a side-by-side from cached financials, not a winner call.
ECB Bancorp Inc. (ECBK) is a banks - regional company listed on US.
Jazz Pharmaceuticals PLC (JAZZ) is a biotechnology company listed on US.
Latest reported ECBK revenue for 2025-12-31 was $598.0K. Net income was $7.8M. Revenue was up 3.6% from 2024-12-31 to 2025-12-31. ECBK currently screens at market cap $146.2M and trailing P/E 28.4.
Latest reported JAZZ revenue for 2026-06-30 was $2.28B. Net income was $485.9M. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
ECBK currently screens at market cap $146.2M and trailing P/E 28.4. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
Not investment advice. Open the ECBK and JAZZ stock pages for the full models.
Not investment advice.